NOT-TR-20-011: Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need

Various due dates.  Check the funding opportunity for details. 

Funder: NIH: National Center for Advancing Translational Sciences (NCATS)

Activity Codes

FOA Title

Applicable Dates

UL1, U01, R21

PA-18-591 - Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)

Applicable Receipt Dates:

  • May 4, 2020
  • November 2, 2020

U01

PAR-19-099 - Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative Innovation Award (U01 Clinical Trial Optional)

Applicable Receipt Dates:

  • July 10, 2020
  • November 9, 2020
  • March 8, 2021
  • July 9, 2021

R21

PAR-19-100 - Limited Competition: Clinical and Translational Science Award (CTSA) Program: Exploratory Collaborative Innovation Awards (R21 Clinical Trial Optional)

Applicable Receipt Dates:

  • July 10, 2020
  • November 9, 2020
  • March 8, 2021
  • July 9, 2021

UL1

PAR-19-337 - Limited Competition: Competitive Revision Awards for the Clinical and Translational Science Award (CTSA) Program (U54 Clinical Trial Optional).

Applicable Receipt Date:

  • September 25, 2020

Learn More Contact OSR to Apply

Topics: Antibody, Clinical Presentation of Infection, Clinical Trial, Co-Morbidities, Community Engagement, Computational Analysis, Diagnostics, Antibody Detection, Economic Impact, ELSI (Ethical, Legal, and Social Implications), Epidemiology, Clinical Outcome, Risk Factors, Aerosol, Health Disparities, Healthcare Implementation, Mobile Health, Prevention, Prognostics, Target Population, Treatments, Antibody-based Treatment, Drug Development, Drug Repurposing, Drug Treatment, Drugs, Vaccine Reliability, Vaccines